Pacifici G M, Kubrich M, Giuliani L, de Vries M, Rane A
Department of Biomedicine, Medical School, University of Pisa, Italy.
Eur J Clin Pharmacol. 1993;44(3):259-64. doi: 10.1007/BF00271368.
Ritodrine is a beta 2-adrenoceptor agonist used for the management of preterm labour. It is inactivated by conjugation with sulphate and glucuronic acid. There is more ritodrine sulphate than ritodrine glucuronide in urine from the newborn whereas equal amounts of ritodrine glucuronide and sulphate are excreted in maternal urine [Clin. Pharmacol. Ther 44, 634-641, 1988]. We show that, in the mid-gestational human fetal liver, ritodrine sulphotransferase is well expressed, whereas the glucuronidation of ritodrine is little developed compared to the adult liver. The average sulphotransferase activity was 308 pmol.min-1 per mg protein in fetal (N = 48) and 145 pmol.min-1 per mg protein in adult (N = 32) liver. The rates of ritodrine sulphation in fetal gut, lung and kidney were higher than in the corresponding adult tissues. The development and tissue distribution patterns of ritodrine sulphotransferase are consistent with those of dopamine sulphotransferase. Ritodrine and dopamine are sulphated by thermolabile enzymes. The activity of glucuronyl transferase was measurable in only 5 of the 48 foetal livers assayed, and in those in which could be assayed, the average activity was 44.6 pmol.min-1 per mg protein, one-tenth of that in adult livers (524 pmol.min-1 per mg protein).
利托君是一种用于治疗早产的β2肾上腺素能受体激动剂。它通过与硫酸盐和葡萄糖醛酸结合而失活。新生儿尿液中利托君硫酸盐的含量高于利托君葡萄糖醛酸化物,而母体尿液中利托君葡萄糖醛酸化物和硫酸盐的排泄量相等[《临床药理学与治疗学》44, 634 - 641, 1988]。我们发现,在妊娠中期的人胎儿肝脏中,利托君磺基转移酶表达良好,而与成人肝脏相比,利托君的葡萄糖醛酸化发育较少。胎儿肝脏(N = 48)中磺基转移酶的平均活性为每毫克蛋白质308 pmol·min-1,成人肝脏(N = 32)中为每毫克蛋白质145 pmol·min-1。胎儿肠道、肺和肾脏中利托君硫酸化的速率高于相应的成人组织。利托君磺基转移酶的发育和组织分布模式与多巴胺磺基转移酶一致。利托君和多巴胺由热不稳定酶硫酸化。在所检测的48个胎儿肝脏中,只有5个可检测到葡萄糖醛酸转移酶的活性,在那些可检测的肝脏中,平均活性为每毫克蛋白质44.6 pmol·min-1,是成人肝脏(每毫克蛋白质524 pmol·min-1)的十分之一。